Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Management Statement

14th Jul 2009 07:00

RNS Number : 6085V
Synergy Health PLC
14 July 2009
 



Tuesday 14 July 2009

SYNERGY HEALTH PLC

("Synergy", "the Company" or "the Group")

Q1 Interim Management Statement

Synergy (SYR.L), a leading provider of outsourced healthcare support services in the UK, Continental Europe, Asia and South Africais pleased to provide an update on its progress since 29 March 2009.

Overall trading has been in line with the Board's expectations. Sales in the first quarter increased 9.7% on the same period last year to £72.6 million (Q1 2007/8£66.2 million). UK sales reflect the planned exit from low margin, non core business lines which masks the continued growth in Decontamination services. Sales in the operating regions were as follows:

Sales Q1 09 

Sales Q1 08

Growth

United Kingdom

£38.8 million

£38.4 million

1.0%

Rest of Europe

£31.6 million

£25.9 million

22.2%

Asia and South Africa

£2.2 million

£1.8 million

17.7%

As reported in JuneSynergy continues to see improvements in its net operating margins and remains on course to have these fully restored by the autumn of this year.

Net debt reduced in the quarter by £17 million to £153 million (28 March 2009: £170 million) reflecting a net generation of free cash of £10 million together with favourable translation of the Euro and Chinese Yuan debt into SterlingThe debt position remains comfortably within covenants agreed with the Company's syndicate of banks. 

Richard Steeves, Chief Executive of Synergy, said:

"The business has had a very positive start to the year and, with a number of new decontamination contracts still to be implemented together with additional sales to be generated from the recent opening of our new sterilisation facilities in Ireland and China, we are pleased to confirm that the business is on track for a successful year."  

Enquiries:

Synergy Health plc

01793 891891 

Dr Richard Steeves, Chief Executive 

Ivan Jacques, Finance Director

Morgan Stanley

020 7677 2395

Peter Moorhouse

Investec

020 7597 5970

Patrick Robb

Financial Dynamics

020 7831 3113

Ben Brewerton

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSCKQKPPBKKNOD

Related Shares:

SYR.L
FTSE 100 Latest
Value8,469.38
Change5.92